[1] TSVETKOV P, COY S, PETROVA B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586): 1254-1261.
[2] LUTSENKO S, ROY S, TSVETKOV P. Mammalian copper homeostasis: physiological roles and molecular mechanisms. Physiol Rev. 2025; 105(1):441-491.
[3] JOMOVA K, MAKOVA M, ALOMAR SY, et al. Essential metals in health and disease. Chem Biol Interact. 2022;367:110173.
[4] EVANS GW. Copper homeostasis in the mammalian system. Physiol Rev. 1973;53(3):535-570.
[5] EVANS GW, BUBOIS RS, HAMBIDGE KM. Wilson’s disease: identification of an abnormal copper-binding protein. Science. 1973;181(4105): 1175-1176.
[6] TIAN Z, JIANG S, ZHOU J, et al. Copper homeostasis and cuproptosis in mitochondria. Life Sci. 2023;334:122223.
[7] JIA D, LIU L, LIU W, et al. Copper metabolism and its role in diabetic complications: A review. Pharmacol Res. 2024;206:107264.
[8] 高红丽,秦玉凤,张玥晗,等.铜代谢与口腔疾病的诊断及治疗[J].中国组织工程研究,2025,29(20):4316-4324.
[9] 朱赛雅,刘晶,余晨.线粒体铜稳态失衡与纤维化疾病的研究进展[J].生理学报,2024,76(4):597-604.
[10] CHANG W, LI P. Copper and Diabetes: Current Research and Prospect. Mol Nutr Food Res. 2023;67(23):e2300468.
[11] POURESMAEIL V, AL ABUDI A H, MAHIMID AH, et al. Evaluation of Serum Selenium and Copper Levels with Inflammatory Cytokines and Indices of Oxidative Stress in Type 2 Diabetes. Biol Trace Elem Res. 2023;201(2):617-626.
[12] WU K, CHEN L, KONG Y, et al. The association between serum copper concentration and prevalence of diabetes among US adults with hypertension (NHANES 2011-2016). J Cell Mol Med. 2024;28(8): e18270.
[13] CUI Z, ZHOU H, LIU K, et al. Dietary Copper and Selenium Intakes and the Risk of Type 2 Diabetes Mellitus: Findings from the China Health and Nutrition Survey. Nutrients. 2022;14(10):2055.
[14] ZHANG Z, JI C, WANG YN, et al. Maresin1 Suppresses High-Glucose-Induced Ferroptosis in Osteoblasts via NRF2 Activation in Type 2 Diabetic Osteoporosis. Cells. 2022;11(16):2560.
[15] LIN Y, SHEN X, KE Y, et al. Activation of osteoblast ferroptosis via the METTL3/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss. FASEB J. 2022;36(3):e22147.
[16] LI Y, SHRESTHA A, ZHANG H, et al. Impact of diabetes mellitus simulations on bone cell behavior through in vitro models. J Bone Miner Metab. 2020;38(5):607-619.
[17] HALL DO, CAMMACK R, RAO KK. Role for ferredoxins in the origin of life and biological evolution. Nature. 1971;233(5315):136-138.
[18] 李朝霞,张晓峰,徐西林,等.铜死亡与骨质疏松[J].中国骨质疏松杂志,2024,30(1):98-103.
[19] SCHULZ V, BASU S, FREIBERT SA, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19(2):206-217.
[20] STEINHILPER R, BOSS L, FREIBERT SA, et al. Two-stage binding of mitochondrial ferredoxin-2 to the core iron-sulfur cluster assembly complex. Nat Commun. 2024;15(1):10559.
[21] JOSHI PR, SADRE S, GUO XA, et al. Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells. J Biol Chem. 2023;299(9):105075.
[22] JIA M, SEN S, WACHNOWSKY C, et al. Characterization of [2Fe-2S]-Cluster-Bridged Protein Complexes and Reaction Intermediates by use of Native Mass Spectrometric Methods. Angew Chem Int Ed Engl. 2020;59(17):6724-6728.
[23] WANG T, LIU Y, LI Q, et al. Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. Front Immunol. 2022;13:999823.
[24] GUOWEI L, XIUFANG L, QIANQIAN X, et al. The FDX1 methylation regulatory mechanism in the malignant phenotype of glioma. Genomics. 2023;115(2):110601.
[25] PARSANATHAN R. Copper’s dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases. Hypertens Res. 2024;47(5):1440-1442.
[26] CHEN J, SUN Q, WANG Y, et al. Revealing the key role of cuproptosis in osteoporosis via the bioinformatic analysis and experimental validation of cuproptosis-related genes. Mamm Genome. 2024;35(3):414-431.
[27] TU B, SONG K, ZHOU ZY, et al. SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis. Eur Heart J. 2025. doi: 10.1093/eurheartj/ehaf130.
[28] DAS A, ASH D, FOUDA AY, et al. Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis. Nat Cell Biol. 2022; 24(1):35-50.
[29] HUO S, WANG Q, SHI W, et al. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury. Int J Mol Sci. 2023;24(2):1667.
[30] QIU Z, LIU Q, WANG L, et al. The copper transporter, SLC31A1, transcriptionally activated by ELF3, imbalances copper homeostasis to exacerbate cisplatin-induced acute kidney injury through mitochondrial dysfunction. Chem Biol Interact. 2024;393:110943.
[31] CHEN X, LI K, XIAO Y, et al. SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration. Biofactors. 2024; 50(5):1009-1023.
[32] SHI X, NI H, TANG L, et al. Comprehensive Gene Analysis Reveals Cuproptosis-Related Gene Signature Associated with M2 Macrophage in Staphylococcus aureus-Infected Osteomyelitis. J Inflamm Res. 2024; 17:3057-3077.
[33] CHEN T, GAO Z, WANG Y, et al. Identification and immunological role of cuproptosis in osteoporosis. Heliyon. 2024;10(5):e26759.
[34] WANG LJ, NI XH, ZHANG F, et al. Osteoblast Response to Copper-Doped Microporous Coatings on Titanium for Improved Bone Integration. Nanoscale Res Lett. 2021;16(1):146.
[35] QI J, ZHENG Z, HU L, et al. Development and characterization of cannabidiol-loaded alginate copper hydrogel for repairing open bone defects in vitro. Colloids Surf B Biointerfaces. 2022;212:112339.
[36] KHALKHALI P, OMIDI M, MASSON-MEYERS DS, et al. Promoting Angiogenesis/Osteogenesis by a New Copper/Magnesium Hydroxide Hybrid Nanoparticle: In Vitro and In Vivo Investigation. J Biomed Mater Res A. 2025;113(1):e37855.
[37] SAFAROVA YANTSEN Y, NESSIPBEKOVA A, SYZDYKOVA A, et al. Strontium- and Copper-Doped Ceramic Granules in Bone Regeneration-Associated Cellular Processes. J Funct Biomater. 2024;15(11):352.
[38] XIE C, SUN Q, CHEN J, et al. Cu-Tremella fuciformis polysaccharide-based tumor microenvironment-responsive injectable gels for cuproptosis-based synergistic osteosarcoma therapy. Int J Biol Macromol. 2024;270(Pt 2):132029.
[39] MEDEIROS C, WALLACE JM. High glucose-induced inhibition of osteoblast like MC3T3-E1 differentiation promotes mitochondrial perturbations. PLoS One. 2022;17(6):e0270001.
[40] ZHANG P, LIAO J, WANG X, et al. High glucose promotes apoptosis and autophagy of MC3T3-E1 osteoblasts. Arch Med Sci. 2023;19(1):138-150.
|